Literature DB >> 19346312

Acute ischemic infarction defined by a region of multiple hypointense vessels on gradient-echo T2* MR imaging at 3T.

D Kaya1, A Dinçer, M E Yildiz, M O Cizmeli, C Erzen.   

Abstract

BACKGROUND AND
PURPOSE: During the hyperacute phase of stroke, multiple hypointense vessels were identified specifically in the ischemic territory on gradient-echo T2*-weighted MR images (GRE-T2* WI) at 3T. The area was named a "region of multiple hypointense vessels (RMHV)." The aim of this study was to assess the usefulness of RMHV for the diagnosis of acute ischemic stroke (AIS) and to establish the relationship of this finding to other MR imaging studies.
MATERIALS AND METHODS: Twenty patients with AIS underwent MR imaging at 3T consisting of GRE-T2*, diffusion-weighted images (DWI), and perfusion-weighted images (PWI) within 6 hours of symptom onset and follow-up images at 72 hours. RMHV was defined as an area containing multiple hypointense vessels strictly in the region of the ischemic territory on GRE-T2*. The RMHV volume on GRE-T2*, initial ischemic lesion volumes on DWI, PWI maps, and on follow-up images were measured and compared with the RMHV volume.
RESULTS: RMHV on GRE-T2* was identified in 20 patients. There was no significant difference between the ischemic lesion volumes on mean transit time (247.3 +/- 88.1 mL), time-to-peak (228.6 +/- 88.8 mL), cerebral blood flow (200.6 +/- 89.7 mL), RMHV on GRE-T2* (214.4 +/- 86 mL), and the infarct volume at 72 hours (210.3 +/- 90.4 mL) (P = .975).
CONCLUSIONS: RMHV on GRE-T2* can be used as a supportive imaging finding for the diagnosis of hyperacute ischemic stroke. RMHV volume provides information that is in accordance with the infarct volume at 72 hours and the data supplied by PWI.

Entities:  

Mesh:

Year:  2009        PMID: 19346312     DOI: 10.3174/ajnr.A1537

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  7 in total

1.  Asymmetrically hypointense veins on T2*w imaging and susceptibility-weighted imaging in ischemic stroke.

Authors:  Ulf Jensen-Kondering; Ruwen Böhm
Journal:  World J Radiol       Date:  2013-04-28

2.  Bright and dark vessels on stroke imaging: different sides of the same coin?

Authors:  Atay Vural; Rahsan Gocmen; Kader Karli Oguz; Mehmet Akif Topcuoglu; Ethem Murat Arsava
Journal:  Diagn Interv Radiol       Date:  2016 May-Jun       Impact factor: 2.630

3.  Post-embolisation susceptibility changes in giant meningiomas: multiparametric histogram analysis using non-contrast-enhanced susceptibility-weighted PRESTO, diffusion-weighted and perfusion-weighted imaging.

Authors:  Tomokazu Nishiguchi; Takeshi Iwakiri; Kohji Hayasaki; Masahiko Ohsawa; Tetuya Yoneda; Yutaka Mitsuhashi; Akimasa Nishio; Vincent Dousset; Yukio Miki
Journal:  Eur Radiol       Date:  2012-09-26       Impact factor: 5.315

4.  Prominent vessel sign on susceptibility-weighted imaging in acute stroke: prediction of infarct growth and clinical outcome.

Authors:  Chia-Yuen Chen; Chin-I Chen; Fong Y Tsai; Ping-Huei Tsai; Wing P Chan
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

Review 5.  GRE T2∗-weighted MRI: principles and clinical applications.

Authors:  Meng Yue Tang; Tian Wu Chen; Xiao Ming Zhang; Xiao Hua Huang
Journal:  Biomed Res Int       Date:  2014-04-16       Impact factor: 3.411

6.  Significance of arterial spin labeling perfusion and susceptibility weighted imaging changes in patients with transient ischemic attack: a prospective cohort study.

Authors:  Inger Havsteen; Lasse Willer; Christian Ovesen; Janus Damm Nybing; Karen Ægidius; Jacob Marstrand; Per Meden; Sverre Rosenbaum; Marie Norsker Folke; Hanne Christensen; Anders Christensen
Journal:  BMC Med Imaging       Date:  2018-08-20       Impact factor: 1.930

7.  Assessment of veins in T2*-weighted MR angiography predicts infarct growth in hyperacute ischemic stroke.

Authors:  Susumu Yamaguchi; Nobutaka Horie; Minoru Morikawa; Yohei Tateishi; Takeshi Hiu; Yoichi Morofuji; Tsuyoshi Izumo; Kentaro Hayashi; Takayuki Matsuo
Journal:  PLoS One       Date:  2018-04-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.